Shift Bioworks develops novel therapeutics by leveraging synthetic biology and AI to engineer microbial systems. Their platform focuses on creating precision medicines that address complex diseases by programming biological functions at the cellular level.
Funding
Funding not disclosed
Founders
Product
Problem
The development of biologic drugs is often a complex, costly, and time-consuming process. Traditional methods lack the efficiency and optimization needed to streamline production and reduce expenses.
Solution
Shift Bioworks offers an automated platform designed to streamline and optimize the process development of biologic drugs. By leveraging synthetic biology and AI, the platform enhances efficiency and reduces costs associated with biologics production. This innovative approach aims to accelerate the discovery and development of new biologic drugs, addressing pressing challenges in human health through integrated solutions.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions involved in the development and production of biologic drugs.
Features
- Automated platform for biologics process development
- AI-driven optimization of biologic drug production
- Streamlined workflows for enhanced efficiency
- Integrated solutions for biologics drug discovery